CMP Therapeutics
Welwyn Garden City
About CMP Therapeutics
CMP Therapeutics, Ltd., a biopharmaceutical company, develops chitin microparticles (CMP) for macrophages and dendritic cells in the nasal and respiratory tract. The company develops a CMP nasal spray for the treatment of allergic rhinitis, as well as for the clinical applications of nasal spray for enhancing natural resistance to influenza and other respiratory pathogens. Its CMP is also used as an adjuvant in nasal vaccines. The company was founded in 2004 and is based in Bicester, the United Kingdom.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.7M
- Last round: Series Unknown (Jul 2010)
- Website: cmptherapeutics.com
- Phone: 44 186 5722 106
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/cmp-therapeutics-1545225 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.